Most of the time, doctors diagnose menopause based on your age, symptoms, and menstrual history, not a single test. The clinical definition is straightforward: menopause is confirmed when you’ve gone 12 consecutive months without a menstrual period, with no other medical explanation for the missed periods. Blood tests exist and are sometimes useful, but they play a supporting role rather than a definitive one.
Why There’s No Single “Menopause Test”
Menopause isn’t a disease with a clear lab marker. It’s a biological transition that unfolds over years, and hormone levels swing dramatically from day to day during that transition. A blood draw on Monday might look perimenopausal while one on Thursday looks normal. That’s why doctors rely first on your pattern of symptoms and your period history, then turn to lab work only when the picture is unclear.
For most women over 45 who have classic symptoms like hot flashes, night sweats, and increasingly irregular periods, no blood test is needed at all. A doctor can make the diagnosis clinically. Testing becomes more important when you’re younger than 45, when your symptoms are ambiguous, or when something else (like a thyroid problem) might explain what you’re experiencing.
The Symptom and Cycle Assessment
Your doctor will typically start by asking about your menstrual cycle patterns. Clinicians use a staging framework that breaks reproductive aging into distinct phases based on how your cycles are changing. In the early transition, the hallmark is a persistent shift of seven or more days in the length of consecutive cycles. If your period used to come every 28 days and now it swings between 24 and 35, that’s a meaningful signal. In the late transition, you start skipping periods entirely, going 60 days or longer without one.
Beyond your cycle, doctors listen for the cluster of symptoms that accompany dropping estrogen: hot flashes, sleep disruption, vaginal dryness, mood changes, difficulty concentrating. No single symptom confirms menopause, but the combination of irregular or absent periods plus vasomotor symptoms (hot flashes, night sweats) in a woman over 45 is considered sufficient for diagnosis without any lab work.
FSH Blood Test
When doctors do order blood work, follicle-stimulating hormone (FSH) is the most common test. FSH is the hormone your brain releases to tell your ovaries to develop an egg each month. As your ovaries wind down and become less responsive, your brain compensates by producing more and more FSH. Average levels rise from about 7 mIU/mL during reproductive years to roughly 46 mIU/mL after menopause. An FSH level above 30 mIU/mL is generally considered consistent with postmenopausal status.
The catch is that FSH fluctuates significantly during perimenopause. You can get a high reading one month and a normal one the next. During the late menopausal transition, FSH levels sometimes spike above 25 IU/L on a random blood draw, but they don’t stay consistently elevated until after your final period. That’s why a single FSH result can’t definitively tell you “you’re in menopause.” It’s one data point, not a verdict.
Estradiol
Doctors sometimes test estradiol, the primary form of estrogen, alongside FSH. After menopause, estradiol typically drops below 10 pg/mL. A low estradiol paired with a high FSH provides stronger confirmation than either test alone. Estradiol levels continue to decrease for about two years after the final menstrual period before stabilizing at their new baseline.
How Birth Control Affects Test Results
If you’re on combined hormonal contraception (the pill, patch, or ring) or hormone replacement therapy, FSH and estradiol tests are essentially unreliable. These medications suppress your natural hormone levels, so a blood draw will reflect the medication rather than your actual menopausal status. Your doctor will need to either interpret your results with that limitation in mind or, in some cases, have you stop hormonal contraception for a period before testing. This is one of the trickier diagnostic situations and a common reason women on birth control feel stuck wondering where they stand.
AMH: Predicting When Menopause Will Arrive
Anti-Müllerian hormone, or AMH, is a newer marker that reflects how many eggs your ovaries have left. Unlike FSH, AMH levels are relatively stable throughout your cycle, making a single blood draw more informative. Research published in the Journal of Clinical Endocrinology and Metabolism found that AMH was a stronger predictor of time to menopause than either FSH or estradiol.
The practical numbers: women aged 45 to 48 with very low AMH (below 0.20 ng/mL) reached menopause in a median of about 6 years, while those with higher AMH (above 1.50 ng/mL) had a median of over 13 years remaining in the youngest age groups studied. Each standard-deviation increase in AMH was associated with a 44% lower chance of reaching menopause in the near term. These are population-level predictions, though, not precise timelines for individual women. AMH testing is more commonly used in fertility planning than in routine menopause diagnosis, but it can help if you’re trying to gauge how far along the transition you are.
Tests That Rule Out Other Conditions
Several conditions mimic menopause convincingly enough that doctors will test for them before settling on a diagnosis, especially in younger women.
- Thyroid function (TSH and free T4): An underactive thyroid causes fatigue, brain fog, muscle aches, and weight changes. An overactive thyroid causes anxiety, sweating, heart palpitations, and insomnia. Both overlap heavily with menopausal symptoms. Routine thyroid screening is recommended for menopausal-age women because these conditions are common and treatable.
- Pregnancy test: Missed periods in a perimenopausal woman can occasionally mean pregnancy rather than menopause, particularly if cycles have been irregular but not absent.
- Prolactin levels: Elevated prolactin from a pituitary issue can stop periods and cause symptoms that overlap with menopause.
Your doctor may also check a basic metabolic panel or complete blood count if your symptoms include fatigue or mood changes, since anemia and other common conditions can layer on top of perimenopause and make everything feel worse.
Physical Exam Findings
A pelvic exam can reveal physical changes consistent with declining estrogen. As estrogen drops, vaginal tissue thins and produces less of the natural secretions that keep the area acidic. In reproductive-age women, vaginal pH stays below 4.5. After menopause, the pH rises as there’s less glycogen in the vaginal walls and fewer of the bacteria that convert it to lactic acid. In the absence of an infection, a vaginal pH above 4.5 strongly suggests low estrogen. This isn’t a standalone diagnostic tool, but it’s a piece of supporting evidence your doctor can gather during a routine exam.
At-Home FSH Tests
Over-the-counter menopause test kits are available at most pharmacies. These urine-based tests detect FSH and are FDA-recognized, with an accuracy rate of about 9 out of 10. Some are identical to kits used in clinical settings. The limitation is the same one that applies to any single FSH measurement: a positive result suggests elevated FSH at that moment, but it can’t account for the hormonal swings of perimenopause. A negative result doesn’t mean you’re not in transition, and a positive result doesn’t confirm you’ve reached menopause.
These kits can be a reasonable starting point if you’re curious and want information before scheduling an appointment, but they work best as a conversation starter with your doctor rather than a final answer.
Diagnosing Early Menopause
The diagnostic approach changes when menopause may be arriving before age 40 (premature ovarian insufficiency) or between 40 and 45 (early menopause). In these cases, doctors rely much more heavily on blood work because waiting a full 12 months without periods isn’t practical when the stakes include fertility and long-term bone and heart health. Expect repeated FSH and estradiol tests, typically drawn on two separate occasions four to six weeks apart, along with thyroid screening and potentially AMH testing. The threshold for investigation is lower, and doctors are more aggressive about confirming the diagnosis because the treatment implications differ from natural menopause at the expected age.